$248.20
0.17% today
NYSE, Feb 28, 05:13 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$247.79
-1.88 0.75% 1M
+17.58 7.64% 6M
+18.47 8.05% YTD
+32.10 14.88% 1Y
+14.76 6.33% 3Y
+90.93 57.97% 5Y
+142.10 134.45% 10Y
NYSE, Closing price Thu, Feb 27 2025
-4.28 1.70%
ISIN
US50540R4092
Symbol
LH
Sector

Key metrics

Market capitalization $20.74b
Enterprise Value $26.51b
P/E (TTM) P/E ratio 28.04
EV/FCF (TTM) EV/FCF 24.19
EV/Sales (TTM) EV/Sales 2.04
P/S ratio (TTM) P/S ratio 1.59
P/B ratio (TTM) P/B ratio 2.57
Dividend yield 1.16%
Last dividend (FY24) $2.88
Revenue growth (TTM) Revenue growth 0.83%
Revenue (TTM) Revenue $13.01b
EBIT (operating result TTM) EBIT $1.14b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $1.52b
EPS (TTM) EPS $8.84
P/E forward 19.80
P/S forward 1.49
EV/Sales forward 1.91
Short interest 3.05%
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Laboratory forecast:

14x Buy
67%
7x Hold
33%

Analyst Opinions

21 Analysts have issued a Laboratory forecast:

Buy
67%
Hold
33%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13,009 13,009
1% 1%
100%
- Direct Costs 9,641 9,641
0% 0%
74%
3,368 3,368
4% 4%
26%
- Selling and Administrative Expenses 1,587 1,587
13% 13%
12%
- Research and Development Expense - -
-
-
1,782 1,782
3% 3%
14%
- Depreciation and Amortization 644 644
9% 9%
5%
EBIT (Operating Income) EBIT 1,138 1,138
0% 0%
9%
Net Profit 746 746
78% 78%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
PRNewsWire
4 days ago
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM , a circulating tumor DNA (ctDNA)-based comprehensive gen...
Positive
Seeking Alpha
15 days ago
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive advantages include large scale, diversified business model, strong industry relationships, and operational efficiency, driving strong revenue and margin expansion. Recent strategic initiatives like t...
Neutral
Seeking Alpha
22 days ago
Labcorp Holdings Inc. (NYSE:LH ) Q4 2024 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Christian O'Donnell - IR Adam Schechter - Chairman and CEO Julia Wang - EVP and CFO Conference Call Participants Michael Cherny - Leerink Partners Jack Meehan - Nephron Research Lisa Gill - JP Morgan Erin Wright - Morgan Stanley Andrew Brackmann - William Blair Pito Chickering - De...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 70,000
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today